Parkman Healthcare Partners LLC Axonics, Inc. Transaction History

Parkman Healthcare Partners LLC

  • $708 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$42.19 - $51.5 $7.47 Million - $9.11 Million
-176,950 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$35.33 - $51.04 $2.3 Million - $3.32 Million
-64,959 Reduced 26.85%
176,950 $9.03 Million
Q1 2020

May 15, 2020
BUY
$16.44 - $37.73 $1.24 Million - $2.86 Million
75,678 Added 45.53%
241,909 $6.15 Million
Q4 2019

Feb 13, 2020
BUY
$19.57 - $28.96 $3.25 Million - $4.81 Million
166,231 New
166,231 $4.61 Million

Others Institutions Holding AXNX

# of Institutions
235
Shares Held
42.1M
Call Options Held
83.4K
Put Options Held
65.3K
View Full List

About Axonics, Inc.

AXNX Quotes by TradingView
  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email